Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

One dead after two-vehicle crash closes major Brampton intersection

June 20, 2026

Montreal man with ALS shares story as awareness month highlights progress, hope

June 20, 2026

SPSA operations vice-president to leave role days after critical wildfire review

June 20, 2026

Germany, Ivory Coast set for World Cup showdown in Toronto

June 20, 2026

AI Crypto Presale Ruvi AI Sells 99% of Phase 3 in Under a Month as Only 1% of Tokens Remain at $0.02

June 20, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment
Press Release

KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment

By News RoomNovember 10, 20242 Mins Read
KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment
Share
Facebook Twitter LinkedIn Pinterest Email

RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) announced a significant advancement in stem cell science, securing a U.S. patent for an innovative method that holds promise for breast cancer treatment and regenerative medicine.

This innovative approach, developed by KFSHRC researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebeh, involves transforming regular breast cells into multipotent stem cells using specialized culture methods. These stem cells have shown the ability to regenerate mammary tissue in animal models, presenting new possibilities for breast tissue reconstruction and advanced cancer therapies. The foundational research supporting this patent was published in the Molecular and Cellular Biology journal.

This innovation offers a promising foundation for personalized breast cancer treatment, potentially providing enhanced reconstruction options for patients during the post-surgery period. Beyond its impact on regenerative medicine, the technique reflects KFSHRC’s dedication to advancing life-saving therapies that address the needs of cancer patients worldwide.

This patent builds on KFSHRC’s 40-year legacy in stem cell innovation, marked by over 7,649 transplants and more than 500 research publications. As a leader in advanced therapies, including localized CAR T-cell treatment for cancer, KFSHRC continues to set new standards in personalized care and transformative medical research to improve therapeutic outcomes for patients worldwide.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/3d130b9c-e2ba-43b3-8793-2eac41e0d912

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

AI Crypto Presale Ruvi AI Sells 99% of Phase 3 in Under a Month as Only 1% of Tokens Remain at $0.02

SaintQuant Launches No-Code AI Crypto Trading Bots, Giving Everyday Investors Hands-Free Access to Automated Markets

PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

PICS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds PicS N.V. (PICS) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

GPK UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Graphic Packaging (GPK) Investors of Securities Class Action Lawsuit Deadline on July 6, 2026

GRAL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

ERAS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

GLOB UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Globant S.A. (GLOB) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

WattCycle Brings a New Performance Class of Balcony Solar Storage to Intersolar Europe 2026

Editors Picks

Montreal man with ALS shares story as awareness month highlights progress, hope

June 20, 2026

SPSA operations vice-president to leave role days after critical wildfire review

June 20, 2026

Germany, Ivory Coast set for World Cup showdown in Toronto

June 20, 2026

AI Crypto Presale Ruvi AI Sells 99% of Phase 3 in Under a Month as Only 1% of Tokens Remain at $0.02

June 20, 2026

Latest News

Musician and YouTuber Hainbach on ‘Breath of the Wild’ and Swiss Army Knives

June 20, 2026

SaintQuant Launches No-Code AI Crypto Trading Bots, Giving Everyday Investors Hands-Free Access to Automated Markets

June 20, 2026

PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

June 20, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version